Skip to main content
aap Implantate AG logo

aap Implantate AG — Investor Relations & Filings

Ticker · AAQ1 ISIN · DE000A3H2101 LEI · 39120001TRQTQ01LPP57 F Manufacturing
Open in API
Filings indexed 854 across all filing types
Latest filing 2013-07-05 Director's Dealing
Country DE Germany
Listing F AAQ1

About aap Implantate AG

https://www.aap.de/

aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.

Recent filings

Filing Released Lang Actions
DGAP-DD: aap Implantate AG english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction made by a person in a managing body (Marek Hahn, Member of a managing body) concerning the company's stock (aap Implantate AG). This directly matches the definition for Director's Dealing (DIRS). The presence of section 15a of the WpHG further confirms this is a regulatory filing related to insider transactions.
2013-07-05 English
DGAP-DD: aap Implantate AG english
Director's Dealing Classification · 100% confidence The document text explicitly contains the header "Directors’ Dealings" and details a transaction (Purchase) by a person in a managing body (Marek Hahn, Member of a managing body) of aap Implantate AG, including the date, price, and number of shares. This directly corresponds to the definition of Director's Dealing (DIRS). The reference to section 15a of the WpHG further confirms this regulatory context for insider transactions.
2013-07-05 English
Datum:04.07.2013
Audit Report / Information Classification · 95% confidence The document is a 'Bericht des Aufsichtsrats' (Supervisory Board Report) for the fiscal year 2012 of aap Implantate AG. It details the board's oversight activities, corporate governance, and the review of the annual financial statements. In German corporate reporting, the Supervisory Board Report is a mandatory component of the Annual Report (Jahresfinanzbericht). Since this document contains the core governance and audit oversight sections of the annual reporting package, it is classified as an Annual Report (10-K equivalent). FY 2012
2013-07-04 German
DGAP-DD: aap Implantate AG english
Director's Dealing Classification · 100% confidence The document text explicitly contains the header "Directors’ Dealings" and details a transaction (Purchase of 5000.00 shares) by a person in a managing body ('Visser, Biense', 'Member of a managing body') of 'aap Implantate AG'. This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS.
2013-07-03 English
aap Implantate AG: Private Equity partner acquires 67% of aap's subsidiary for Orthopaedic products for the Asian market
M&A Activity Classification · 99% confidence The document is an 'Ad-hoc' announcement dated June 28, 2013, disseminated according to § 15 WpHG (German Securities Trading Act). The content details a significant corporate event: a joint venture agreement where a Private Equity firm acquires a 67% stake in a subsidiary (aap Joints GmbH). This type of announcement concerns a major transaction affecting the company's structure and future outlook, but it is not a standard periodic financial report (like 10-K or IR), a management discussion (MDA), or a specific financing event (CAP). It is a material, non-scheduled corporate action disclosure. Since it is a material corporate event announcement that doesn't fit the specific categories like M&A (TAR - which usually implies a takeover bid or full merger), the most appropriate general category for significant, non-standard corporate news that must be disclosed immediately is 'Regulatory Filings' (RNS), as it is a mandatory disclosure via the DGAP service.
2013-06-28 English
Q1-Bericht 2013
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (Quartalsbericht) for Q1 2013, containing detailed financial tables (sales, EBITDA, EBIT, cash flow, balance sheet) and a 'Foreword by the Board of Management' discussing business performance and strategy. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2013
2013-05-15 German

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.